As awareness of the importance of hormones and their health implications grows, the hormone health industry will continue to evolve and expand at rapid rates. Over the past several decades, hormone replacement therapy (HRT) has experienced a surge in popularity, driven by increased advertising, growing accessibility, and treatment innovations. Now increasingly provided under the wing of personalized medicine, hormone therapies are currently used to treat menopause, andropause, thyroid disorders, hypogonadism, as well as other disorders of the endocrine system. As the prevalence of these conditions is on the rise, so is patient demand for HRT solutions, and more specifically bio-identical hormone-based products. At this time, incorporating hormonal health solutions into your service offering provides a great opportunity for practice expansion and patient growth.
Commonly prescribed to menopausal patients, individuals with human growth hormone and thyroid imbalances, as well as males with hypogonadism, hormone replacement therapies (HRT) have had a tumultuous history within the medical industry and scientific community. Despite several ups and downs, these therapeutics are now widely popularized solutions to hormonal imbalances, specifically menopause, and constitute a global, high-revenue market. Additionally, research developments have contributed to the introduction of bio-identical hormone-based products, which provide a natural alternative to synthetic HRTs and have been surging in popularity.
\With the advent of telemedicine came several challenges not limited to IT security, patient-provider connection, and a host of technological issues. As the adoption of digital medical care is now relatively widespread, there is a new challenge facing telehealth – distraction. According to new survey data, approximately 44% of Americans engaged in a telehealth appointment during the COVID-19 pandemic and a significant proportion of those also reported multi-tasking or being distracted by other tasks during their visit.